CompletedPhase 2NCT00662012

Sodium Stibogluconate Treatment of Leishmaniasis

Studying Leishmaniasis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
U.S. Army Medical Research and Development Command
Principal Investigator
Glenn Wortmann, MD
Walter Reed Army Medical Center, Infectious Disease
Intervention
Sodium Stibogluconate (SSG)(drug)
Enrollment
414 target
Eligibility
All sexes
Timeline
2002 – 2007

Study locations (1)

Collaborators

Walter Reed Army Medical Center

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00662012 on ClinicalTrials.gov

Other trials for Leishmaniasis

Additional recruiting or active studies for the same condition.

See all trials for Leishmaniasis →

← Back to all trials